Ann Partridge

92PUBLICATIONS
417CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPsychosocial aspects of childbirth and perinatal mental healthCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (92)

|Aug 20, 2026
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.

|Jul 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

|May 19, 2026
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer.

|Apr 30, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.

|Jan 15, 2026
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study.

Carmine Valenza, Yue Zheng, Monica Milano

|Dec 19, 2025
Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer.

Amin H Nassar, Elias Bou Farhat, Hassan Abushukair

Pageof 16

Frequent Collaborators

27 joint publications

Kathryn Ruddy

17 joint publications

Shoshana Rosenberg

17 joint publications

Sara Tolaney

14 joint publications

Eric Winer